Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
AvKare – Recall of ranitidine
November 14, 2019 - AvKare announced a voluntary, consumer-level recall of prescription ranitidine due to potential N-nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
